Phase I clinical trial of cisplatin given i.v. with 5-fluorouracil and high-dose folinic acid James L. AbbruzzeseRobert AmatoPhilip Frost OriginalPaper Pages: 159 - 162
The influence of Na+, K+-pump blockade on doxorubicin-mediated cytotoxicity and DNA strand breakage in human tumor cells Theodore S. LawrenceMary A. Davis OriginalPaper Pages: 163 - 167
Modulation of the cytotoxic mechanism of 6-thioguanine by 4-amino-5-imidazolecarboxamide Jonathan MaybaumCatherine W. MorgansClare E. Rogers OriginalPaper Pages: 168 - 172
The chemotherapeutic potential of glycol alkyl ethers: structure-activity studies of nine compounds in a Fischer-rat leukemia transplant model Michael P. DieterCharles W. JamesonAndrew G. Braun OriginalPaper Pages: 173 - 180
Increased therapeutic effect on metastatic liver tumors in rats of two-route chemotherapy usingcis-diamminedichloroplatinum (II) and its antidote, sodium thiosulfate, with temporary clamping of the abdominal aorta Keitaro HasudaHiroaki KobayashiTsuneo Baba OriginalPaper Pages: 181 - 187
Quantitative subcellular distribution of platinum in rat tissues following i. v. bolus and i. v. infusion of cisplatin Rajesh PartiWalter Wolf OriginalPaper Pages: 188 - 192
Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models Toshiharu NaritaShin-ichi YaguchiShigeru Tsukagoshi OriginalPaper Pages: 193 - 197
Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage? Ralph E. Durand OriginalPaper Pages: 198 - 204
Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and dose Gerard W. M. VisserGeertrui C. M. GorreeJacobus D. M. Herscheid OriginalPaper Pages: 205 - 209
Extracorporeal hemofiltration: a model for decreasing systemic drug exposure with intra-arterial chemotherapy Roger A. GrahamZahid H. SiddikDavid C. Hohn OriginalPaper Pages: 210 - 214
Evaluation ofp-F-Phe-m-bis-(2-chloroethyl)amino-l-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia Mary Jane YagiJ. George Bekesi OriginalPaper Pages: 215 - 220
Phase II study of tallysomycin S10b in patients with advanced colorectal cancer C. NicaiseJ. AjaniI. Krakoff OriginalPaper Pages: 221 - 222
Evaluation of continuous-infusion alpha-difluoromethylornithine therapy for colorectal carcinoma Jaffer A. AjaniDavid M. OtaKenji Nishioka OriginalPaper Pages: 223 - 226
Cardiovascular autonomic function in anthracycline-treated breast cancer patients Maria ViniegraMarcelo MarchettiPedro M. Politi OriginalPaper Pages: 227 - 231
Carboplatin is ototoxic Ian C. S. KennedyBernard M. FitzharrisChristopher H. Atkinson Short Communication Pages: 232 - 234
Acute nonlymphocytic leukemia following chemotherapy with cisplatin and etoposide for non-small-cell carcinoma of the lung: case report Daniel BrenezJacques DevriendtJacqueline Schmerber Short Communication Pages: 235 - 236
Phase I study of mitozolomide on a once daily for 5 days schedule Jan H. SchornagelGodelaine SimonettiJ. Gordon McVie Short Communication Pages: 237 - 238
A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatin L. AgliettiF. RoilaA. Del Favero Short Communication Pages: 239 - 240